Back to Search
Start Over
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1.
- Source :
-
The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2023 Apr; Vol. 33, pp. 100762. Date of Electronic Publication: 2023 Apr 12. - Publication Year :
- 2023
-
Abstract
- Competing Interests: X.S.X. and Y.C. are the inventors of the provisional patent applications for BD series neutralizing antibodies and are founders of Singlomics Biopharmaceuticals. All other authors declare no competing interests.
Details
- Language :
- English
- ISSN :
- 2666-6065
- Volume :
- 33
- Database :
- MEDLINE
- Journal :
- The Lancet regional health. Western Pacific
- Publication Type :
- Academic Journal
- Accession number :
- 37069895
- Full Text :
- https://doi.org/10.1016/j.lanwpc.2023.100762